Trademark: RYPLAZIM PLASMINOGEN
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
RYPLAZIM PLASMINOGEN
Click here to search for trademarks similar to RYPLAZIM PLASMINOGEN
Proof of use for RYPLAZIM PLASMINOGEN
We do not have any records of a proof of use for RYPLAZIM PLASMINOGEN at this moment.
Possible trademark infringements of RYPLAZIM PLASMINOGEN
Basic Information about RYPLAZIM PLASMINOGEN
- Serial Number
- 87247936
- Filing Date
- 25 Nov 2016
- Registration Number
- 5929629
- Registration Date
- 10 Dec 2019
- Mark Drawing Code
- 3
Classifications
Declare the trademark use of RYPLAZIM PLASMINOGEN on the blockchain with WikiTrademarks.io.
- First use of RYPLAZIM PLASMINOGEN anywhere
- No first use declared yet.
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 006; 018; 044; 046; 051; 052
Who owns RYPLAZIM PLASMINOGEN?
1. KEDRION BIOPHARMA INC. FORT LEE NJ
2. ProMetic BioTherapeutics, Inc. Rockville MD
3. ProMetic BioTherapeutics, Inc. Rockville MD
4. ProMetic BioTherapeutics, Inc. Rockville MD
Correspondent
- Lindsay Jones
- Merchant & Gould P.C.
- P.O. Box 2910
- Minneapolis,MN 55402-0910
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io